(Updates)
** Shares of medical device maker Medtronic Plc MDT.N down
~6% at $82.44
** Stock among top losers on S&P 500 index .SPX
** Co forecasts fiscal 2024 adjusted EPS of $5 to $5.10,
below Refinitiv IBES estimates of $5.20, as a stronger dollar
weighs
** BTIG analyst Ryan Zimmerman says the co's revenue
forecast is also below its long-term guidance
** Co, however, reported Q4 adjusted profit of $1.57/shr,
edging past estimates of $1.56/shr, helped by a recovery in
non-urgent surgical procedures
** Separately, Medtronic said it will buy South Korea-based
insulin patch maker EOFlow 294090.KQ for a total consideration
of 971 billion won ($738 million)
** MDT shares are up ~6% this year
(Reporting by Raghav Mahobe)
((Raghav.Mahobe@thomsonreuters.com;))